Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 01, 2020

BUY
$14.47 - $27.96 $38,316 - $74,038
2,648 Added 11.02%
26,678 $476,000
Q1 2019

Apr 30, 2019

SELL
$31.58 - $46.35 $179,974 - $264,148
-5,699 Reduced 19.17%
24,030 $807,000
Q4 2018

Feb 08, 2019

SELL
$30.43 - $56.65 $2,008 - $3,738
-66 Reduced 0.22%
29,729 $977,000
Q3 2018

Oct 29, 2018

SELL
$46.46 - $68.49 $1,393 - $2,054
-30 Reduced 0.1%
29,795 $1.82 Million
Q2 2018

Aug 02, 2018

BUY
$46.25 - $104.45 $268,018 - $605,287
5,795 Added 24.12%
29,825 $1.46 Million
Q1 2018

May 01, 2018

SELL
$57.4 - $108.44 $20.5 Million - $38.8 Million
-357,560 Reduced 93.7%
24,030 $2.55 Million
Q4 2017

Feb 02, 2018

BUY
$23.02 - $60.5 $8.11 Million - $21.3 Million
352,413 Added 1207.85%
381,590 $22.8 Million
Q3 2017

Oct 30, 2017

BUY
$17.79 - $24.0 $519,058 - $700,248
29,177
29,177 $700,000

Others Institutions Holding NKTR

About NEKTAR THERAPEUTICS


  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $219M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Public Employees Retirement Association Of Colorado Portfolio

Follow Public Employees Retirement Association Of Colorado and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement Association Of Colorado, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement Association Of Colorado with notifications on news.